Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Form: White Lyophilized Powder

Blend Composition: 20mg Triple Agonist (Retatrutide) + 5mg Eloralintide per vial (25mg total)

Molecular Formula: N/A — blend; see component data below

Molecular Weight: N/A — blend; see component data below

Triple Agonist — CAS Number: 2381089-83-2
Triple Agonist — Chemical Name: Retatrutide
Triple Agonist — Synonyms: LY3437943
Triple Agonist — Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Triple Agonist — Molecular Weight: 4,731.4 g/mol
Triple Agonist — Sequence: 39-amino acid acylated synthetic peptide; C20 fatty diacid conjugated via a gamma-glutamic acid/mini-PEG linker at Lys¹⁷

Eloralintide — CAS Number: 2883634-40-8
Eloralintide — Chemical Name: Eloralintide
Eloralintide — Synonyms: LY3841136; LY-3841136
Eloralintide — Molecular Formula: C₂₀₁H₃₁₉N₄₉O₆₅S₂
Eloralintide — Molecular Weight: ~4,526.1 g/mol
Eloralintide — Sequence: Synthetic, lipidated long-acting amylin analog peptide

Purity: ≥98% each component (HPLC) — see batch COA

Form: Lyophilized white to off-white powder

Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.

Solubility: Soluble in sterile water or 0.1% acetic acid at ≥1 mg/mL

Certificate of Analysis: Available for all batches.

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.